アプタマー アフェレシス 核酸医薬の開発|タグシクス・バイオ株式会社

News

rss
2017.10.7
Event Presentation schedule in November
2017.10.7
Event Presentation schedule in October
2017.2.1
News Release TAGCyx has executed a research and development collaboration agreement with a European biopharma company in February. The partnership will continue for 2 years which is extendable with mutual agreement and will apply the TAGcyx platform towards the identificatio
2016.8.31
News Release TagCyx announces the completion of 500 million Japanese Yen (US$ 4.9 Million, as of Aug. 31, 2016) private financing, led by The University of Tokyo Edge Capital as a lead investor, and SMBC Venture Capital, Nissay Capital CO., LTD. (Aug 2016)